UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058309
Receipt number R000066487
Scientific Title Characteristics and predictors of fulminant progression in patients with acute myocarditis
Date of disclosure of the study information 2025/08/01
Last modified on 2025/06/28 21:40:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics and predictors of fulminant progression in patients with acute myocarditis (REACTION study)

Acronym

Characteristics and predictors of fulminant progression in patients with acute myocarditis

Scientific Title

Characteristics and predictors of fulminant progression in patients with acute myocarditis

Scientific Title:Acronym

REACTION study

Region

Japan


Condition

Condition

acute myocarditis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the predictors of fulminant progression in patients with acute myocarditis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

fulminant progression (requiring mechanical circulatory support)

Key secondary outcomes

In-hospital death, heart transplantation, or left ventricular assist device implantation.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients hospitalized with a diagnosis of acute myocarditis.

Key exclusion criteria

Cases that do not meet the guideline-based diagnostic criteria for acute myocarditis

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Sho
Middle name
Last name Suzuki

Organization

Shinshu University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

3908621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

+81263373486

Email

jersey0042@gmail.com


Public contact

Name of contact person

1st name Takenori
Middle name
Last name Aoki

Organization

Shinshu University School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

3908621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

+81263373486

Homepage URL


Email

aoki_takenori@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

Shinshu University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Institutional Review Board

Address

3-1-1,Asahi,Matsumoto,Nagano

Tel

+81263372572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 30 Day

Date of IRB

2025 Year 05 Month 30 Day

Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2030 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2025 Year 06 Month 28 Day

Last modified on

2025 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066487